10x Genomics Blog Feb 15, 2026 Assessing 10x Genomics (TXG) Valuation After Recent Share Price Momentum - simplywall.st
10x Genomics Blog Feb 14, 2026 10x Genomics Cancer Alliances Test AI Ambitions Against Mixed Share Performance - Yahoo Finance
Lonza News Feb 14, 2026 Lonza’s Stock In Recovery Mode: Is This Swiss CDMO Finally Back On Track? - AD HOC NEWS
Lonza News Feb 14, 2026 Lonza’s Stock In Recovery Mode: Is This Swiss CDMO Finally Back On Track? - AD HOC NEWS
Agilent Feb 14, 2026 The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News - simplywall.st
Endpoints News Feb 14, 2026 Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more
Thermo Fisher Feb 14, 2026 Thermo Fisher Scientific (TMO) Announces $3.8 Billion Senior Not - GuruFocus
Agilent Feb 14, 2026 The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News - Sahm
Illumina Feb 14, 2026 Illumina (NASDAQ:ILMN) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
10x Genomics Blog Feb 14, 2026 Compared to estimates, 10x Genomics (TXG) Q4 earnings: A look at key metrics - MSN
10x Genomics Blog Feb 14, 2026 Risk Factors Weigh on 10X Genomics: Uncertain Guidance, Stock Volatility, and Capital-Raising Challenges - TipRanks
10x Genomics Blog Feb 14, 2026 Shrinking TTM Loss At 10x Genomics (TXG) Tests Bearish Earnings Narratives - simplywall.st
10x Genomics Blog Feb 14, 2026 Shrinking TTM Loss At 10x Genomics (TXG) Tests Bearish Earnings Narratives - simplywall.st